Keyphrases
Interferon-α (IFN-α)
100%
Virus Pathogenesis
100%
Respiratory Syncytial Virus
100%
Respiratory Viruses
100%
Th-2
20%
Virus Diseases
20%
Formalin
20%
Whole-cell Vaccine
20%
Respiratory Syncytial Virus Vaccines
20%
Pneumonia
10%
T Cell Lines
10%
6 Months of Age
10%
Virus Challenge
10%
Reinfection
10%
Vaccine Development
10%
Cytokine Pattern
10%
Alum
10%
β-adrenoceptor
10%
Lower Respiratory Infections
10%
Bronchiolitis
10%
Initial Infection
10%
Eosinophilic Inflammation
10%
Specific Intent
10%
Virus Infection
10%
Clinical Trials
10%
Knock-in Mouse Model
10%
Respiratory Syncytial Virus Infection
10%
Maternal Antibodies
10%
Illness
10%
Vaccine Preparation
10%
Hospitalization
10%
Infants under 6 Months
10%
Vaccine Strategy
10%
Interferon-γ
10%
Vaccinated children
10%
Next-generation Vaccines
10%
Beta-gamma
10%
Influenza-like Illness
10%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Interferon Alfa
100%
Respiratory Virus
100%
Respiratory Syncytial Virus Vaccine
20%
Influenza
10%
Maternal Antibody
10%
T Cell
10%
Knockout Mouse
10%
Respiratory Syncytial Virus Infection
10%
Virus Vaccine
10%
Inactivated Virus Vaccine
10%
Systemic-Onset Juvenile Idiopathic Arthritis
10%
Bronchiolitis
10%
Viral Disease
10%
Cell Line
10%
Cytokine
10%
Immunity
8%